Company Overview of Reliance GeneMedix Limited
Reliance GeneMedix Limited, together with its subsidiaries, develops, manufactures, and distributes biotechnology pharmaceuticals. The company’s biosimilars are a generic version of recombinant therapeutic proteins. Its product under development includes EPOSTIM, a erythropoietin alpha that is used as a support therapy for the treatment of acute, chronic, and end-stage renal failure; in cancer-induced and chemotherapy related anemia; in patients undergoing major surgeries; and in AIDS patients on zidovudine treatment. The company is headquartered in Tullamore, Ireland. Reliance GeneMedix Limited is a subsidiary of Reliance Life Sciences Pvt. Ltd.
IDA Business & Technology Park
353 5 793 23572
353 5 793 23592
Key Executives for Reliance GeneMedix Limited
Reliance GeneMedix Limited Key Developments
Similar Private Companies By Industry
|Alexo Therapeutics Ltd||Europe|
|Algae Health Ltd.||Europe|
|Alimentary Health Limited||Europe|
|Benthic Labs Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Reliance GeneMedix Limited, please visit www.genemedix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.